Xijin Zhang

Dr. Xijin Zhang


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2020 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
HZHai-Tao Zhang
Hai-Tao Zhang
JZJin-Song Zhang
Jin-Song Zhang
HZHai-Hua Zhang
Hai-Hua Zhang
YNYan-Dong Nan
Yan-Dong Nan
YZYing Zhao
Ying Zhao
TZTao Zhang
Tao Zhang

27 November 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YLYi Li
Yi Li
LYLu Yin
Lu Yin
ZFZhongmin Fan
Zhongmin Fan
BSBinxiao Su
Binxiao Su
YCYu Chen
Yu Chen
XZXijin Zhang
Xijin Zhang
Neurological dysfunction, one of the severe manifestations of sepsis in patients, is closely related to increased mortality and long-term complications in intensive care units, including sepsis-associated encephalopathy (SAE) and chronic pain. The underlying mechanisms of these sepsis-induced neurological dysfunctions are elusive. However, it has been well established that microglia, the dominant resident immune cell in the central nervous system, play essential roles in the initiation and development of SAE and chronic pain. Microglia can be activated by inflammatory mediators, adjacent cells and neurotransmitters in the acute phase of sepsis and then induce neuronal dysfunction in the brain. With the spotlight focused on the relationship between microglia and sepsis, a deeper understanding of microglia in SAE and chronic pain can be achieved. More importantly, clarifying the mechanisms of sepsis-associated signaling pathways in microglia would shed new light on treatment strategies for SAE and chronic pain.

1 April 2021 in Brain Research
Verified
Journal Article
Closed access
JWJiajia Wang
Jiajia Wang
SWShiquan Wang
Shiquan Wang
HGHaiyun Guo
Haiyun Guo
YLYi Li
Yi Li
ZJZhenhua Jiang
Zhenhua Jiang
ZFZongping Fang
Zongping Fang

24 October 2021 in Critical Care
Verified
Journal Article
Open access
PDF file
YYYun Yan
Yun Yan
YCYu Chen
Yu Chen
XZXijin Zhang
Xijin Zhang
Gastrointestinal (GI) dysfunction is common in the critical care setting and is highly associated with clinical outcomes. Opioids increase the risk for GI dysfunction and are frequently prescribed to reduce pain in critically ill patients. However, the role of opioids in GI function remains uncertain in the ICU. This review aims to describe the effect of opioids on GI motility, their potential risk of increasing infection and the treatment of GI dysmotility with opioid antagonists in the ICU setting.

17 April 2020 in medRxiv
Verified
Preprint
Open access
PDF file
XZXianfei Zeng
Xianfei Zeng
HFHongyan Fan
Hongyan Fan
DLDongxue Lu
Dongxue Lu
FHFang Huang
Fang Huang
XMXi Meng
Xi Meng
XHXing-Bin Hu
Xing-Bin Hu
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become the third most common coronavirus that causes large-scale infections worldwide. The correlations between pathogen susceptibility and blood type distribution have attracted attention decades ago. The current retrospective study aimed to examine the correlation between blood type distribution and SARS-CoV-2 infection, progression, and prognosis in patients with coronavirus disease 2019 (COVID-19). With 265 patients from multiple medical centers and two established cohorts, we found that the blood type A population was more sensitive to SARS-CoV-2. Moreover, the blood type distribution was not relevant to acute respiratory distress syndrome (ARDS), acute kidney injury (AKI), and mortality in COVID-19 patients. These findings are indicative of coping with the great threat since it probed the relationship between blood types and ARDS, AKI, and mortality, in addition to susceptibility in COVID-19 patients.

10 January 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
HMHongwei Ma
Hongwei Ma
YYYongheng Yang
Yongheng Yang
TNTiejian Nie
Tiejian Nie
RYRong Yan
Rong Yan
YSYue Si
Yue Si
FZFanglin Zhang
Fanglin Zhang
Hantaan virus (HTNV) is asymptomatically carried by rodents, yet causes lethal hemorrhagic fever with renal syndrome in humans, the underlying mechanisms of which remain to be elucidated. Here, we show that differential macrophage responses may determine disparate infection outcomes. In mice, late-phase inactivation of inflammatory macrophage prevents cytokine storm syndrome that usually occurs in HTNV-infected patients. This is attained by elaborate crosstalk between Notch and NF-κB pathways. Mechanistically, Notch receptors activated by HTNV enhance NF-κB signaling by recruiting IKKβ and p65, promoting inflammatory macrophage polarization in both species. However, in mice rather than humans, Notch-mediated inflammation is timely restrained by a series of murine-specific long noncoding RNAs transcribed by the Notch pathway in a negative feedback manner. Among them, the lnc-ip65 detaches p65 from the Notch receptor and inhibits p65 phosphorylation, rewiring macrophages from the pro-inflammation to the pro-resolution phenotype. Genetic ablation of lnc-ip65 leads to destructive HTNV infection in mice. Thus, our findings reveal an immune-braking function of murine noncoding RNAs, offering a special therapeutic strategy for HTNV infection.